Is a complete TVGN research report available?

No complete published report is available for Tevogen Bio Holdings Inc. (TVGN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Tevogen Bio Holdings Inc. (TVGN)

NASDAQ: TVGN · USD

$6.72

+0.78 (+13.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TVGN analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	28.4M
Net income (ttm)	-21.9M
EPS (ttm)	-$6.48
Shares out	4.2M
Volume	24,206
Beta	0.22

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -21.9M
EPS (ttm): -$6.48
Market cap: 28.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All TVGN indicators

Market & fundamental data

Available fields

159

Groups with data

Currency

USD

Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001860871
Company name	Tevogen Bio Holdings Inc.
Country	United States
Country code	US
Cusip	88165K200
Employees	18
Enterprise value	$37M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US88165K2006
Last refreshed	2026-07-31
Market cap	$28.4M
Market cap category	Nano-Cap
Price	$6.72
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2836
Symbol	TVGN
Website	https://tevogen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-77.85%
FCF yield	-41.93%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-21.9M
Net Income Growth Quarters	4%
Net Income Growth Years	0%
Profit Per Employee	$-1.2M
ROA	-294.4
ROCE	902.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-87.1%
Cagr3y	-76.78%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$4.9M
Cash	$692,305
Current Assets	$2.1M
Current Liabilities	$7.3M
Debt	$9.5M
Equity	$-9.8M
Interest Coverage	-87.46
Liabilities	$14.8M
Long Term Assets	$2.8M
Long Term Liabilities	$7.5M
Net Cash	$-8.8M
Net Cash By Market Cap	$-31.15
Tangible Book Value	$-18.6M
Tangible Book Value Per Share	$-4.47
WACC	4.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.29
Net Working Capital	$-3.8M
Quick ratio	0.12
Working Capital	$-5.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.82%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-87.08%
200-day SMA	13.61
3Y total return	-98.75%
50-day SMA	7.55
50-day SMA vs 200-day SMA	50under200
All Time High	1,054.5
All Time High Change	-99.36%
All Time High Date	2024-02-15
All Time Low	3.64
All Time Low Change	84.82%
All Time Low Date	2026-07-20
ATR	0.81
Beta	0.22
Beta1y	2.53
Beta2y	1.24
Ch YTD	-59.41
High	7.42
High52	70
High52 Date	2025-08-05
High52ch	-90.4%
Low	6.12
Low52	3.64
Low52 Date	2026-07-20
Low52ch	84.82%
Ma50ch	-10.97%
Price vs 200-day SMA	-50.63%
RSI	57.77
RSI Monthly	28.8
RSI Weekly	38.5
Sharpe ratio	-1.25x
Sortino ratio	-1.71
Total Return	-10.82%
Tr YTD	-59.41
Tr1m	6.84%
Tr1w	52.38%
Tr3m	4.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-2.5
Operating Income	$-21.2M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	3,400,000
Shares Insiders	108.39%
Shares Institutions	3.4%
Shares Out	4,219,343
Shares Qo Q	69.72%
Shares Yo Y	10.82%
Short Ratio	3
Short Shares	1.54

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-23.6M
Adjusted OCF	-23,534,035
Average Volume	15,209.95x
Bv Per Share	-4.47
CAPEX	$-64,439
Ch1m	6.84
Ch1w	52.38
Ch1y	-87.08
Ch3m	4.67
Ch3y	-98.75
Ch6m	-54.97
Change	13.13%
Change From Open	9.8
Close	5.94
Days Gap	3.03
Depreciation Amortization	180,288
Dollar Volume	162,664.3
Earnings Date	2026-08-14
Earnings Time	amc
EBIT	$-21.2M
EBITDA	$-20.7M
EPS	$-6.48
F Score	1
FCF	$-11.8M
FCF EV Yield	-31.97x
FCF Per Share	$-2.8
Financing CF	10,536,095
Fiscal Year End	December
Founded	2,020
Investing CF	-64,439
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2026-03-06
Last Split Type	Reverse
Last10k Filing Date	2026-03-31
Ma150	9.72
Ma150ch	-30.87%
Ma20	5.07
Ma20ch	32.6%
Net CF	-1,282,627
Next Earnings Date	2026-08-13
Open	6.12
Optionable	No
Position In Range	46.15
Post Close	6.72
Postmarket Change Percent	0
Postmarket Price	$6.72
Ppne	1,534,730
Price Date	2026-07-30
Relative Volume	1.59x
Share Based Comp	11,779,752
Tr6m	-54.97%
Us State	New Jersey
Volume	24,206

Tevogen Bio Holdings Inc. (TVGN)

Coverage state: Market snapshot only — no published research

Generate the first TVGN analysis

Price

Financial snapshot

Fair-value bridge

Latest news · TVGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TVGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TVGN

Frequently asked questions